MicroRNA-146a in autoimmunity and innate immune responses

Edward K L Chan, Angela Ceribelli, Minoru Satoh

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

MicroRNA (miRNA) are approximately 22 nucleotide single-stranded RNA that regulate the stability of target messenger RNA by selective binding to specific sites at the 30-untranslated regions (UTR). This triggers repression in translation and mRNA degradation. It has been estimated that approximately 60% of all mRNA are under the control of miRNA. Among the known hundreds of miRNA, some are considered master regulators controlling either a single or multiple cellular pathways. Some miRNA are known to affect development and cell differentiation, while others are implicated in immunity and autoimmune diseases. A very interesting example is miR-146a, which has been reported to be downregulated in systemic lupus erythematosus and upregulated in rheumatoid arthritis (RA). Several groups have recently focused their attention on miRNA in the pathogenesis of RA. Interestingly, the expression of miR-146a is upregulated in different cell types and tissues in RA patients. miRNA in RA could also be considered as possible future targets for new therapeutic approaches. This discussion will focus on the current understanding in the function of miR-146a in endotoxin tolerance and cross-tolerance, and how it may contribute to modulate the overproduction of known pathogenic cytokines, such as tumour necrosis factor α.

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume72
Issue numberSUPPL. 2
DOIs
Publication statusPublished - Apr 2013

Fingerprint

MicroRNAs
Autoimmunity
Innate Immunity
Rheumatoid Arthritis
RNA Stability
Messenger RNA
Untranslated Regions
Endotoxins
Systemic Lupus Erythematosus
Autoimmune Diseases
Cell Differentiation
Immunity
Down-Regulation
Nucleotides
Tumor Necrosis Factor-alpha
RNA
Tissue
Cytokines
Degradation

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Allergy

Cite this

MicroRNA-146a in autoimmunity and innate immune responses. / Chan, Edward K L; Ceribelli, Angela; Satoh, Minoru.

In: Annals of the Rheumatic Diseases, Vol. 72, No. SUPPL. 2, 04.2013.

Research output: Contribution to journalArticle

Chan, Edward K L ; Ceribelli, Angela ; Satoh, Minoru. / MicroRNA-146a in autoimmunity and innate immune responses. In: Annals of the Rheumatic Diseases. 2013 ; Vol. 72, No. SUPPL. 2.
@article{2cee2ae2bc0f4b36a1e67988dd4aad3d,
title = "MicroRNA-146a in autoimmunity and innate immune responses",
abstract = "MicroRNA (miRNA) are approximately 22 nucleotide single-stranded RNA that regulate the stability of target messenger RNA by selective binding to specific sites at the 30-untranslated regions (UTR). This triggers repression in translation and mRNA degradation. It has been estimated that approximately 60{\%} of all mRNA are under the control of miRNA. Among the known hundreds of miRNA, some are considered master regulators controlling either a single or multiple cellular pathways. Some miRNA are known to affect development and cell differentiation, while others are implicated in immunity and autoimmune diseases. A very interesting example is miR-146a, which has been reported to be downregulated in systemic lupus erythematosus and upregulated in rheumatoid arthritis (RA). Several groups have recently focused their attention on miRNA in the pathogenesis of RA. Interestingly, the expression of miR-146a is upregulated in different cell types and tissues in RA patients. miRNA in RA could also be considered as possible future targets for new therapeutic approaches. This discussion will focus on the current understanding in the function of miR-146a in endotoxin tolerance and cross-tolerance, and how it may contribute to modulate the overproduction of known pathogenic cytokines, such as tumour necrosis factor α.",
author = "Chan, {Edward K L} and Angela Ceribelli and Minoru Satoh",
year = "2013",
month = "4",
doi = "10.1136/annrheumdis-2012-202203",
language = "English",
volume = "72",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "SUPPL. 2",

}

TY - JOUR

T1 - MicroRNA-146a in autoimmunity and innate immune responses

AU - Chan, Edward K L

AU - Ceribelli, Angela

AU - Satoh, Minoru

PY - 2013/4

Y1 - 2013/4

N2 - MicroRNA (miRNA) are approximately 22 nucleotide single-stranded RNA that regulate the stability of target messenger RNA by selective binding to specific sites at the 30-untranslated regions (UTR). This triggers repression in translation and mRNA degradation. It has been estimated that approximately 60% of all mRNA are under the control of miRNA. Among the known hundreds of miRNA, some are considered master regulators controlling either a single or multiple cellular pathways. Some miRNA are known to affect development and cell differentiation, while others are implicated in immunity and autoimmune diseases. A very interesting example is miR-146a, which has been reported to be downregulated in systemic lupus erythematosus and upregulated in rheumatoid arthritis (RA). Several groups have recently focused their attention on miRNA in the pathogenesis of RA. Interestingly, the expression of miR-146a is upregulated in different cell types and tissues in RA patients. miRNA in RA could also be considered as possible future targets for new therapeutic approaches. This discussion will focus on the current understanding in the function of miR-146a in endotoxin tolerance and cross-tolerance, and how it may contribute to modulate the overproduction of known pathogenic cytokines, such as tumour necrosis factor α.

AB - MicroRNA (miRNA) are approximately 22 nucleotide single-stranded RNA that regulate the stability of target messenger RNA by selective binding to specific sites at the 30-untranslated regions (UTR). This triggers repression in translation and mRNA degradation. It has been estimated that approximately 60% of all mRNA are under the control of miRNA. Among the known hundreds of miRNA, some are considered master regulators controlling either a single or multiple cellular pathways. Some miRNA are known to affect development and cell differentiation, while others are implicated in immunity and autoimmune diseases. A very interesting example is miR-146a, which has been reported to be downregulated in systemic lupus erythematosus and upregulated in rheumatoid arthritis (RA). Several groups have recently focused their attention on miRNA in the pathogenesis of RA. Interestingly, the expression of miR-146a is upregulated in different cell types and tissues in RA patients. miRNA in RA could also be considered as possible future targets for new therapeutic approaches. This discussion will focus on the current understanding in the function of miR-146a in endotoxin tolerance and cross-tolerance, and how it may contribute to modulate the overproduction of known pathogenic cytokines, such as tumour necrosis factor α.

UR - http://www.scopus.com/inward/record.url?scp=84876285817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876285817&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2012-202203

DO - 10.1136/annrheumdis-2012-202203

M3 - Article

C2 - 23253933

AN - SCOPUS:84876285817

VL - 72

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - SUPPL. 2

ER -